INNOVATIONS in Pharmacy

University of Minnesota Libraries Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in
Follow this journal
PrintDownload PDF

About the journal

INNOVATIONS in Pharmacy is an open-access journal published by University of Minnesota Libraries Publishing in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
University of Minnesota Libraries Publishing
ISSN
2155-0417
Country
United States
Languages
english
Access
Open access
Articles in DOAJ
1089
Declared review time
16 weeks
Declared peer-review model
peer_review
Official website
https://pubs.lib.umn.edu/index.php/innovations/index

Index listings

  • DOAJ · 2012-06-03
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
16 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1089

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

976

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

25

i10-index

164

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2024-03-17
Added to DOAJ
2012-06-03
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
0%
ORCID iDs in current deposits
63%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Innov Pharm
Source type
journal
NLM unique ID (PubMed)
101574764
Classification2

Subjects (DOAJ)

Medicine: Pharmacy and materia medica

LCC codes

RS1-441

Subject areas

  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Medication Adherence and Compliance
  • Medication Adherence and Compliance
  • Innovations in Medical Education
  • Innovations in Medical Education
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
Show all subjects (50)
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Health Sciences Research and Education
  • Health Sciences Research and Education
  • Patient Safety and Medication Errors
  • Patient Safety and Medication Errors
  • Interprofessional Education and Collaboration
  • Interprofessional Education and Collaboration
  • Antibiotic Use and Resistance
  • Antibiotic Use and Resistance
  • Innovative Teaching Methods
  • Innovative Teaching Methods
  • Problem and Project Based Learning
  • Problem and Project Based Learning
  • Pharmacy and Medical Practices
  • Pharmacy and Medical Practices
  • Primary Care and Health Outcomes
  • Health Policy Implementation Science
  • Primary Care and Health Outcomes
  • Health Policy Implementation Science
  • Healthcare Policy and Management
  • Mobile Health and mHealth Applications
  • Healthcare cost, quality, practices
  • Healthcare Policy and Management
  • Healthcare cost, quality, practices
  • Mobile Health and mHealth Applications
  • Pharmaceutical industry and healthcare
  • Pharmaceutical industry and healthcare
  • Diabetes Management and Education
  • Diabetes Management and Education
  • Vaccine Coverage and Hesitancy
  • Vaccine Coverage and Hesitancy
  • Opioid Use Disorder Treatment
  • Opioid Use Disorder Treatment
  • Health and Medical Research Impacts
  • Health and Medical Research Impacts
  • Blood Pressure and Hypertension Studies
  • Health Literacy and Information Accessibility
  • Health Literacy and Information Accessibility
  • Blood Pressure and Hypertension Studies

Keywords (DOAJ)

  • pharmacy practice
  • pharmacy policy
  • pharmacy education

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: